Hyun-Il Cho

NovaCell Technology (South Korea) — South Korea

Immunology and Microbiology · Life Sciences

16h-index1.4kcitations97works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(48), CAR-T cell therapy research(34), Immune Cell Function and Interaction(22), vaccines and immunoinformatics approaches(20), Cancer Immunotherapy and Biomarkers(19)

Publications97 total

Abstract 1788: A novel costimulatory signaling domain for chimeric antigen receptor-engineering
Cancer Research·2023
Data from Sustained Persistence of IL2 Signaling Enhances the Antitumor Effect of Peptide Vaccines through T-cell Expansion and Preventing PD-1 Inhibition
2023Open Access
Supplementary Figure Legends from Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
2023Open Access
Data from Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
2023Open Access
Supplementary Figure 1 from Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
2023Open Access
Supplementary Figure 4 from Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
2023Open Access
Supplementary Figure 1 from Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
2023Open Access
Supplementary Figure 2 from Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
2023Open Access
Supplementary Figure 2 from Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
2023Open Access
Data from Sustained Persistence of IL2 Signaling Enhances the Antitumor Effect of Peptide Vaccines through T-cell Expansion and Preventing PD-1 Inhibition
2023Open Access
Supplementary Figure 4 from Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
2023Open Access
Supplementary Figures from Sustained Persistence of IL2 Signaling Enhances the Antitumor Effect of Peptide Vaccines through T-cell Expansion and Preventing PD-1 Inhibition
2023Open Access
Supplementary Figure 3 from Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
2023Open Access
Data from Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
2023· 1 citedOpen Access
Supplementary Figure 3 from Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
2023Open Access
Supplementary Figure Legends from Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
2023Open Access
Supplementary Figures from Sustained Persistence of IL2 Signaling Enhances the Antitumor Effect of Peptide Vaccines through T-cell Expansion and Preventing PD-1 Inhibition
2023Open Access
Data from Autophagy Induced by Conventional Chemotherapy Mediates Tumor Cell Sensitivity to Immunotherapy
2023Open Access
Supplementary Figures 1-5 from A Potent Vaccination Strategy That Circumvents Lymphodepletion for Effective Antitumor Adoptive T-cell Therapy
2023Open Access
Data from Optimized Peptide Vaccines Eliciting Extensive CD8 T-Cell Responses with Therapeutic Antitumor Effects
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Tai‐Gyu Kim(29), Hyun‐Jung Sohn(21), Esteban Celis(15), Dae-Hee Sohn(7), Hussein Sultan(6), Takumi Kumai(6), Hiroya Kobayashi(6), Yasuaki Harabuchi(6), Dmitry I. Gabrilovich(5), Hyun-Joo Lee(5), A-Ri Shin(5), Seung‐Joo Hyun(4), Sueon Kim(4), Chun-Choo Kim(4), Hyun Joo Lee(4), Su Jin Lee(4), Rupal Ramakrishnan(4), Huang Chun(4), Mark Lloyd(4), Joseph Johnson(4)